- Stocks
- Healthcare
- NASDAQ: CNMD

Price (delayed)

$136.01

Market cap

$3.97B

P/E Ratio

72.35

Dividend/share

$0.8

EPS

$1.88

Enterprise value

$4.65B

The stock's price to earnings (P/E) is 94% less than its last 4 quarters average of 1157.5 and 82% less than its 5-year quarterly average of 401.8

CONMED's gross profit has increased by 16% YoY and by 15% QoQ

CNMD's quick ratio is down by 8% YoY

What are the main financial stats of CNMD

Market
Valuations
Earnings

Shares outstanding

29.16M

Market cap

$3.97B

Enterprise value

$4.65B

Price to earnings (P/E)

72.35

Price to book (P/B)

5.31

Price to sales (P/S)

4.05

EV/EBIT

46.64

EV/EBITDA

39.66

EV/Sales

4.75

Revenue

$978.5M

EBIT

$99.69M

EBITDA

$117.25M

Free cash flow

$102.58M

Per share
Balance sheet
Liquidity

EPS

$1.88

Free cash flow per share

$3.52

Book value per share

$25.59

Revenue per share

$33.6

TBVPS

$22.56

Total assets

$1.76B

Total liabilities

$1.02B

Debt

$729.68M

Equity

$744.5M

Working capital

$244.72M

Debt to equity

0.98

Current ratio

2.23

Quick ratio

1.09

Net debt/EBITDA

5.83

Margins
Efficiency
Dividend

EBITDA margin

12%

Gross margin

55.1%

Net margin

5.5%

Operating margin

10.2%

Return on assets

3.1%

Return on equity

7.6%

Return on invested capital

8.6%

Return on capital employed

6.4%

Return on sales

10.2%

Dividend yield

0.59%

DPS

$0.8

Payout ratio

42.6%

How has the CONMED stock price performed over time

Intraday

-1.4%

1 week

1.31%

1 month

-2.06%

1 year

64.78%

YTD

21.44%

QTD

-1.03%

How have CONMED's revenue and profit performed over time

Revenue

$978.5M

Gross profit

$539.09M

Operating income

$99.69M

Net income

$54.14M

Gross margin

55.1%

Net margin

5.5%

The operating income has soared by 150% year-on-year and by 89% since the previous quarter

The operating margin has surged by 122% year-on-year and by 70% since the previous quarter

CONMED's gross profit has increased by 16% YoY and by 15% QoQ

CNMD's revenue is up by 12% year-on-year and by 11% since the previous quarter

What is CONMED's growth rate over time

What is CONMED stock price valuation

P/E

72.35

P/B

5.31

P/S

4.05

EV/EBIT

46.64

EV/EBITDA

39.66

EV/Sales

4.75

The stock's price to book (P/B) is 66% more than its 5-year quarterly average of 3.2 and 15% more than its last 4 quarters average of 4.6

CNMD's equity is up by 10% YoY and by 2.6% from the previous quarter

CNMD's P/S is 62% more than its 5-year quarterly average of 2.5 and 9% more than its last 4 quarters average of 3.7

CNMD's revenue is up by 12% year-on-year and by 11% since the previous quarter

How efficient is CONMED business performance

CNMD's return on invested capital has surged by 161% year-on-year and by 91% since the previous quarter

CNMD's ROS has soared by 122% YoY and by 70% QoQ

What is CNMD's dividend history

DPS

$0.8

Dividend yield

0.59%

Payout ratio

42.6%

Recent dividends

How did CONMED financials performed over time

CNMD's total assets is 73% greater than its total liabilities

The current ratio has contracted by 11% YoY and by 4.3% from the previous quarter

CNMD's quick ratio is down by 8% YoY

The company's debt to equity fell by 18% YoY and by 4.9% QoQ

CNMD's equity is up by 10% YoY and by 2.6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.